HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Erythrocyte phosphoglycerate kinase deficiency: enzymatic and oxygen binding studies.

Abstract
Enzyme and oxygen transport studies have been made on seven members of a kindred with red cell deficiency of phosphoglycerate kinase (PGK), an enzyme known to be linked to the X-chromosome. The two affected males were children, had little detectable PGK activity and had severe neurological damage. Both had moderate haemolytic anaemia complicated by the occurrence of haemolytic crises. Red cell ATP levels were substantially decreased in both subjects. However, they had more than double the normal level of 2,3-diphosphoglycerate (2,3-DPG) in their red cells, associated with a rightward shift in their oxygen-haemoglobin equilibrium curves. This shift in the curve was sufficient to permit oxygen delivery to most body tissues, including the brain, at better tensions than normal, except during a haemolytic crisis. Two of the three known heterozygotes were aged over 70. They had moderate haemolytic anaemia, considerable reduction of red cell PGK activity (19% and 35% of normal, respectively), and considerable increase in red cell 2,3-DPG with rightward shifting of the oxygen-haemoglobin equilibrium curve. The other known heterozygote was aged 22 and showed little abnormality in her blood oxygen transport.
AuthorsS J Dodgson, C S Lee, R A Holland, W J O'Sullivan, M R Vowels
JournalAustralian and New Zealand journal of medicine (Aust N Z J Med) Vol. 10 Issue 6 Pg. 614-21 (Dec 1980) ISSN: 0004-8291 [Print] Australia
PMID6938182 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Adenosine Triphosphate
  • Phosphoglycerate Kinase
  • Oxygen
Topics
  • Adenosine Triphosphate (metabolism)
  • Adolescent
  • Adult
  • Aged
  • Child
  • Child, Preschool
  • Erythrocytes (enzymology)
  • Female
  • Humans
  • Male
  • Oxygen (metabolism)
  • Pedigree
  • Phosphoglycerate Kinase (deficiency)
  • Sex Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: